PubMed was used for data mining of the nucleic acid sequence for human beta-globin chain following by in silico assignment of mutation corresponding to Hb D Punjab. The in silico combination between nucleic acid sequence for human Hb D Punjab beta-globin chain and U7.623 was done and tested for the expression by ontology prediction method. [5] 
Introduction
Of several hemoglobinopathies identified in India, hemoglobin (Hb) D Punjab disorder is a disorder firstly described in India. [1, 2] This is a hematological disorder due to defect in beta-globin gene (beta 121 Glu → Gln). Since it is a genetic disorder, therefore, there is no specific treatment at the root cause in the previous day. However, due to the recent medical technology in the present, the treatment based on gene therapy becomes feasible.
Of several gene therapy techniques, the repair of defective splicing by small nuclear ribonucleic acids (snRNAs) is a new modality for treatment of hemoglobinopathy. The principle of using snRNA is aiming at replacement of the natural antisense sequence with that targeted to the desired RNA with the expectation for permanent expression of RNA antisense to the specific defective thalassemic splice sites in beta-globin RNA. [3] Here, the author assesses the possibility of U7.623 gene therapy for Hb D Punjab disorder. A standard bioinformatic analysis to study the effect of co-expression between nucleic acid sequence for human Hb D Punjab beta-globin chain and U7.623 was performed.
Materials and Methods
This work is performed as a bioinformatics study. The protocol in this work is the same as standard referenced work published by Wiwanitkit. [4] Briefly, the database
